Last edition
News about "NLRP3 Inflammasome"
Johns Hopkins Researchers Identify Human Resistin as Key Driver of Inflammatory Pathway
Researchers found that blocking human resistin with a targeted antibody reduced activation of the NLRP3 inflammatory pathway, pointing to a potential target for future therapies.
NLRP3 Inflammasome | 07/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members